JUNB and plasma cell myeloma: Intriguingly, aberrantly expressed JunB facilitates the progression of ccRCC, multiple myeloma, and several lymphomas through transcriptionally promoting the production of chemokines, inflammatory cytokines, and growth factors within the TME.